PURPLE Company Overview, Contact Details & Competitors

Q: What is PURPLE's official website and social media links?

PURPLE's official website is purplepr.com. PURPLE has social profiles on LinkedIn.

Q: How many employees does PURPLE have currently?

PURPLE has approximately 510 employees.

Q: What technology does PURPLE use?

PURPLE's tech stack includes Yoast SEO, jQuery, UPS, Twitter, Apple iCloud Mail.

Insights

Gathering insights about PURPLE…

Similar companies to PURPLE

PURPLE Tech Stack

PURPLE uses 8 technology products and services including Bloomberg, Google Cloud, jQuery, and more. Explore PURPLE's tech stack below.

Bloomberg
Accounting And Finance
Google Cloud
Infrastructure As A Service
jQuery
Javascript Libraries
Microsoft
Miscellaneous
Google Sheets
Office Suites
Vercel
Platform As A Service
Tailwind CSS
UI Frameworks
Pinterest
Visual And User Generated Content Marketing

Media & News

Purple Biotech (NASDAQ:PPBT) Shares to Reverse Split on Monday, March 2nd
Purple Biotech Ltd. Sponsored ADR (NASDAQ: PPBT) shares are going to reverse split on the morning of Monday, March 2nd. The 1-10 reverse split was announced on Wednesday, February 11th. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, March 1st. Purple Biotech Trading Up 0.5%
Feb 14, 2026 | www.defenseworld.net
Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress
New data showcase the versatility and anti-tumor activity of the CAPTN-3 platform and its unique multi-arm design in treatment-resistant cancers REHOVOT, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, today announced that it will present new preclinical data from its CAPTN-3 platform of conditionally activated tri-specific antibodies at the upcoming European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress being held from December 10–12, 2025, in London, United Kingdom.
Dec 04, 2025 | www.globenewswire.com
Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update
Initiated development of a second CAPTN-3 tri-specific antibody targeting TROP2 Manufacturing milestone achieved for IM1240, the first tri-specific 5T4-targeting antibody from the CAPTN-3 platform Cash position of $10.5 million as of September 30, 2025, with an anticipated cash runway into the first half of 2027, supporting the development of our CAPTN-3 technology platform through significant milestones REHOVOT, Israel, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, announced today financial results for the three months ended September 30, 2025, and provided a business update.
Nov 14, 2025 | www.globenewswire.com
Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform
Achieved commercially viable yield for IM1240, positioning the program competitively for future development Validates scalability of the CAPTN-3 tri-specific antibody platform IM1240, the first CAPTN-3 tri-specific antibody targeting the novel tumor-associated antigen 5T4, advances toward first-in-human clinical trials, with an Investigational New Drug (IND) submission planned for 2026 REHOVOT, Israel, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or the “Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, today announced the achievement of a manufacturing milestone for IM1240, a tri-specific antibody from the CAPTN-3 platform, which targets the tumor-associated antigen 5T4, the activating receptor CD3 on T cells and the inhibitory receptor NKG2A on NK and CD8⁺ T cells.
Oct 29, 2025 | www.globenewswire.com
Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification
REHOVOT, Israel, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, today announced that on October 16, 2025, it received a letter from the Listings Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rules for continued listing on the Nasdaq Capital Market, as the closing bid price for the Company's American Depositary Shares (ADSs) has been below the minimum $1.00 per share requirement under Nasdaq Listing Rule 5550(a)(2) for 30 consecutive trading days.
Oct 20, 2025 | www.globenewswire.com
Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants
REHOVOT, Israel, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, today announced the closing of its previously announced public offering of an aggregate of 5,999,999 of the Company's American Depositary Shares (ADSs) (or pre-funded warrants in lieu thereof), with each ADS representing 200 ordinary shares, and short-term warrants to purchase up to 11,999,998 ADSs, at a combined public offering price of $1.00 per share (or pre-funded warrant in lieu thereof) and accompanying short-term warrants. The short-term warrants have an exercise price of $1.00 per ADS, are exercisable immediately upon issuance and will expire twenty-four months from the date of issuance.
Sep 05, 2025 | www.globenewswire.com
Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
REHOVOT, Israel, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, today announced that the Company's CEO, Gil Efron will participate in a fireside chat and 1x1 investor meeting at the H.C. Wainwright 27th Annual Global Investment Conference, being held September 8-10, 2025.
Aug 27, 2025 | www.globenewswire.com

PURPLE's Email Address Formats

PURPLE uses at least 1 format(s):

PURPLE Email Formats	Example	Percentage
First.Last@purplepr.com	John.Doe@purplepr.com	84%
First@purplepr.com	John@purplepr.com	14%
FirstL@purplepr.com	JohnD@purplepr.com	1%
FirstLast@purplepr.com	JohnDoe@purplepr.com	1%

Frequently Asked Questions

Where is PURPLE's headquarters located?

PURPLE's main headquarters is located at 27-29 Glasshouse Street London, England United Kingdom. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is PURPLE's phone number?

You can contact PURPLE's main corporate office by phone at

+1-646-710-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is PURPLE's stock symbol?

PURPLE is a publicly traded company; the company's stock symbol is PPBT.

What is PURPLE's official website and social media links?

PURPLE's official website is purplepr.com and has social profiles on LinkedIn.

What is PURPLE's SIC code NAICS code?

PURPLE's SIC code is 7011 - Hotels and Motels NAICS code is 54182 - Public Relations Agencies.

How many employees does PURPLE have currently?

As of February 2026, PURPLE has approximately 510 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: F. L.Vice President - Vip, Events & Partnerships: K. L.Vice President Of Beauty And Wellbeing: K. G.. Explore PURPLE's employee directory with LeadIQ.

What industry does PURPLE belong to?

PURPLE operates in the Public Relations and Communications Services industry.

What technology does PURPLE use?

PURPLE's tech stack includes BloombergGoogle CloudjQueryMicrosoftGoogle SheetsVercelTailwind CSSPinterest.

What is PURPLE's email format?

PURPLE's email format typically follows the pattern of First.Last@purplepr.com. Find more PURPLE email formats with LeadIQ.

When was PURPLE founded?

PURPLE was founded in 1997.

Insights

Similar companies to PURPLE

Violet

Grape

MAGENTA

Indigo

Thistle

Plum

Mulberry

Orchid

PURPLE Tech Stack

Media & News

Purple Biotech (NASDAQ:PPBT) Shares to Reverse Split on Monday, March 2nd

Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress

Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update

Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform

Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification

Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants

Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

PURPLE's Email Address Formats

Frequently Asked Questions

Where is PURPLE's headquarters located?

What is PURPLE's phone number?

What is PURPLE's stock symbol?

What is PURPLE's official website and social media links?

What is PURPLE's SIC code NAICS code?

How many employees does PURPLE have currently?

What industry does PURPLE belong to?

What technology does PURPLE use?

What is PURPLE's email format?

When was PURPLE founded?

PURPLE

Company Overview

Media & News

Purple Biotech (NASDAQ:PPBT) Shares to Reverse Split on Monday, March 2nd

Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress

Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?